Coping with Information Loss and the Use of Auxiliary Sources of Data: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions

While the SARS-CoV-2 (COVID-19) pandemic has led to an impressive and unprecedented initiation of clinical research, it has also led to considerable disruption of clinical trials in other disease areas, with around 80% of non-COVID-19 trials stopped or interrupted during the pandemic. In many cases...

Full description

Saved in:
Bibliographic Details
Published inStatistics in biopharmaceutical research Vol. 16; no. 2; pp. 141 - 157
Main Authors Calderazzo, Silvia, Tarima, Sergey, Reid, Carissa, Flournoy, Nancy, Friede, Tim, Geller, Nancy, Rosenberger, James L, Stallard, Nigel, Ursino, Moreno, Vandemeulebroecke, Marc, Van Lancker, Kelly, Zohar, Sarah
Format Journal Article
LanguageEnglish
Published Taylor & Francis 02.04.2024
American Statistical Association
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:While the SARS-CoV-2 (COVID-19) pandemic has led to an impressive and unprecedented initiation of clinical research, it has also led to considerable disruption of clinical trials in other disease areas, with around 80% of non-COVID-19 trials stopped or interrupted during the pandemic. In many cases the disrupted trials will not have the planned statistical power necessary to yield interpretable results. This article describes methods to compensate for the information loss arising from trial disruptions by incorporating additional information available from auxiliary data sources. The methods described include the use of auxiliary data on baseline and early outcome data available from the trial itself and frequentist and Bayesian approaches for the incorporation of information from external data sources. The methods are illustrated by application to the analysis of artificial data based on the Primary care pediatrics Learning Activity Nutrition (PLAN) study, a clinical trial assessing a diet and exercise intervention for overweight children, that was affected by the COVID-19 pandemic. We show how all of the methods proposed lead to an increase in precision relative to use of complete case data only.
ISSN:1946-6315
1946-6315
DOI:10.1080/19466315.2023.2211023